Craddock C, Slade D, Santo C De, Wheat R, Ferguson P, Hodgkinson A, Brock K, Cavenagh J, Ingram W, Dennis M, Malladi R, Siddique S, Mussai F and Yap C (2018) Combination lenalidomide and azacitidine: a novel salvage therapy in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia (in press; Journal of Clinical Oncology)
Wheeler GM, Mander AP, Bedding A, Brock K, Cornelius V, Grieve AP, Jaki T, Love S, Odondi L, Weir C, Yap C and Bond SJ (2018) How to design a dose-finding study using the Continual Reassessment Method. BMC medical research methodology (in press; BMC Med Res Methodol.)
Mergental H, Stephenson BTF, Laing RW, Kirkham AJ, Neil DA, Wallace LL, Boeton YL, Widmer J, Bhogal RH, Perera MT, Smith A, Reynolds GM, Yap C, Hübscher SG, Mirza DF, Afford SC (2018). Development of Clinical Criteria for Functional Assessment to Predict Primary Non-function of High-risk Livers using Normothermic Machine Perfusion. Liver Transplantation, 24(10), 1453-1469
Pallman P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, Holmes J, Mander A, Odondi Lang’o, Sydes MR, Villar S, Wason JMS, Weir CJ, Wheeler GM, Yap C, Jaki T (2018) Adaptive designs in clinical trials: why use them, and how to run and report them. BMC medicine, 16(1), 29.
Mander A, Wheeler G and Yap C (2018). Practical implementation of dose-response adaptive trials. Wiley StatsRef: Statistics Reference Online. 1–6.
Yap C and Cheung YK (2018). Sequential elimination in multi-arm multi-stage selection trials. Wiley StatsRef: Statistics Reference Online.
Yap C, Billingham LJ, Cheung YK, Craddock, C and O'Quigley, J (2017). Dose Transition Pathways: The missing link between complex dose-finding designs and simple decision-making. Clinical Cancer Research, pp.clincanres-0582.
Brock K, Billingham L, Copland M, Yap C. “Implementing the EffTox Dose-Finding Design in the Matchpoint Trial”. BMC Research Methodology 2017, 17(1), 112
Newsome PN,Fox R,…..,Yap C and Forbes SJ (2017) “REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC), a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis.” Lancet Hep and Gastro 2017
Harrison C, Mead A, Panchal A, Fox S, Yap C, Houlton A et al (2017) “Ruxolitinib vs Best Available Therapy in patients with ET who are intolerant or resistant to Hydroxycarbamide” Blood, 2017
Laing RW, Mergental H, Yap C, Kirkham A, Whilku M, Barton D, ... & Perera MTP (2017). Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single-arm trial. BMJ open, 7(11), e017733.
Pratt G, Yap C, Oldreive C, Slade D, Bishop R, Griffiths M, Dyer MJS, Fegan C, Oscier D, Pettitt A, Matutes E, Devereux S, Allsup D, Bloor A, Hillmen P, Follows G, Rule S, Moss P and Stankovic T (2017), A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. Br J Haematol. doi:10.1111/bjh.14793
Love, SB, Brown, S, Weir, CJ, Harbron, C, Yap, C, Gaschler-Markefski, B, Matcham, J, Caffrey, L, McKevitt, C, Clive, S and Craddock, C et al (2017). Embracing model-based designs for dose-finding trials. British journal of cancer, 117(3), p.332.
Craddock C, Jilani N, Siddique S, Yap C, Khan J, Nagra S, Ward J, Ferguson P, Hazlewood P, Buka R, Vyas P (2015). Tolerability and clinical activity of post-transplantation azacitidine in patients allografted for acute myeloid leukemia treated on the RICAZA trial. Biology of Blood and Marrow Transplantation. 29;22(2):385-90.
Mussai, FJ, Yap, C, Mitchell, C, & Kearns, P (2015): Challenges of Clinical Trial Design for Targeted Agents Against Pediatric Leukemias. Frontiers in Oncology, 4, 374
Yap, C, Lin, X, & Cheung, YKK (2015). Sequential Elimination in Multi-Arm Selection Trials. Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects, 81, 411-426, edited by Sverdlov, A (ed)
Yap C, Pettitt A and Billingham L (2013): Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia. BMC Med Res Methodol. 2013; 13: 87.
Yap C, Beverland IJ, Heal MR, Cohen GR, Robertson C, Henderson DEJ, Ferguson NS, Hart CL, Morris G and Agius RM (2012): Association between long-term exposure to air pollution and specific causes of mortality in Scotland. Occupational and Environmental Medicine, 2012, 69:916-924
Beverland I, Robertson C, Yap C, Heal MR, Cohen, GR, Henderson DEJ, Hart CL and Agius, RM (2012) Comparison of models for estimation of long-term exposure to air pollution in cohort studies. Atmospheric Environment, 62. 530-539.
Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, McDonald AC (2006) Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. International Journal of Radiation Oncology, Biology, Physics 66(2): 505-13
Beverland IJ, Cohen GR, Heal MR, Carder M, Yap C, Robertson C, Hart CL and Agius RM (2012): A Comparison of Short-term and Long-term Air Pollution Exposure Associations with Mortality in Two Cohorts in Scotland Environ Health Perspect. 2012; 120(9): 1280–1285.
Walji N, Chue A L, Yap C, Rogers L J, El-Modir A, Chan K K, Singh K, Fernando. I N (2010): Is There a Role for Adjuvant Hysterectomy after Suboptimal Concurrent Chemoradiation in Cervical Carcinoma? Clinical Oncology 2010, 22(2), 140–146
King A, Barton D, Beard H, Moore J, Than N, Corbett C, Thomas J, Guo K, Guha I, Hollyman D, Stocken D, Yap C, Fox R, Forbes SJ and Newsome PN (2015): Repeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC), a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis: study protocol for a randomised controlled trial. BMJ open 5.3 (2015): e007700.
Tho LM, McIntyre A, Rosst A, Gallagher C, Yap C, Ritchie DM, Canney PA (2006) Acute Supraclavicular Skin Toxicity in Patients Undergoing Radiotherapy for Breast Cancer; An Evaluation of the “T” Grip Method of Patient Positioning. Clinical Oncology 18(2):133-8